<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05097170</url>
  </required_header>
  <id_info>
    <org_study_id>GO-21/704</org_study_id>
    <nct_id>NCT05097170</nct_id>
  </id_info>
  <brief_title>Cerebral Oxygenation and Awareness During VT Ablation</brief_title>
  <official_title>Determining the Effect of Vital Parameters on Cerebral Oxygenation and Awareness During Ventricular Tachycardia Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is aimed to examine the effect of the decrease in blood pressure that occurs during the&#xD;
      ventricular tachycardia ablation process on cerebral oxygenation and awareness.&#xD;
&#xD;
      Patient's age, cardiac measurements (ejection fraction-EF), basal vital values, procedure&#xD;
      time (especially activation and pacing mapping), and localization of the arrhythmia, may&#xD;
      affect the NIRS and BIS response to blood pressure drop. In addition to the effects of&#xD;
      patients' demographic information, cardiac capacity and procedure time on NIRS and BIS values&#xD;
      (downtrend and duration), correlations of these values with other monitoring parameters&#xD;
      (ETCO2 and SpO2) intended to be displayed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 18, 2021</start_date>
  <completion_date type="Anticipated">April 18, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 18, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NIRS</measure>
    <time_frame>perioperative (VT ablation)</time_frame>
    <description>cerebral oxygenation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BIS</measure>
    <time_frame>perioperative (VT ablation)</time_frame>
    <description>awareness</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cerebral Oxygenation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>patients under the age of 65</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>patients above the age of 65</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NIRS during ventricular tachycardia ablation</intervention_name>
    <description>NIRS: Near-infrared spectroscopy is a measurement technique that non-invasively and continuously monitors the balance between cerebral oxygen consumption and delivery.&#xD;
BIS: BIS is an electroencephalogram-derived parameter developed to monitor the hypnotic effects of anesthesia.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>BIS during ventricular tachycardia ablation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing VT ablation procedure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over the age of 18&#xD;
&#xD;
          -  Patients who will undergo VT ablation&#xD;
&#xD;
          -  Patients who want to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients whose baseline values could not be obtained before induction&#xD;
&#xD;
          -  Patients with severe neurological or psychiatric illness&#xD;
&#xD;
          -  Patients who do not want to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Filiz Uzumcugil, MD</last_name>
    <phone>+903123051260</phone>
    <email>filizuzumcugil@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elif Kilic Cakmak, MD</last_name>
    <phone>+903123051260</phone>
    <email>elfklc4@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Shivkumar K. Catheter Ablation of Ventricular Arrhythmias. N Engl J Med. 2019 Apr 18;380(16):1555-1564. doi: 10.1056/NEJMra1615244. Review.</citation>
    <PMID>30995375</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Filiz Uzumcugil</investigator_full_name>
    <investigator_title>MD, Associate Prof.</investigator_title>
  </responsible_party>
  <keyword>cerebral oxygenation, ventricular tachycardia ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

